Related Experiment Video

Updated: Mar 18, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency

Aurélia Noll1, Giuditta Illuzzi1, Jean-Christophe Amé1

  • 1Biotechnology and Cell Signalling, UMR7242 CNRS, Université de Strasbourg, Laboratory of Excellence Medalis, ESBS, 300 Bd Sébastien Brant, CS 10413, 67412 Illkirch, France.

Cancer Cell International
|July 5, 2016
PubMed
Abstract

Insights

Poly(ADP-ribose) glycohydrolase (PARG) depletion showed mild sensitivity in some BRCA1-deficient tumor cells. However, PARG deficiency is not a viable strategy for killing BRCA1- or PTEN-mutated cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Poly(ADP-ribose) polymerase (PARP) inhibitors are used in cancer therapy, particularly for BRCA-mutated tumors.
  • Poly(ADP-ribose) glycohydrolase (PARG) deficiency can enhance the effects of DNA-damaging agents.
  • This study investigates PARG deficiency's impact on tumor cells with BRCA1 and/or PTEN mutations.

Purpose of the Study:

  • To determine if PARG deficiency sensitizes BRCA1- and/or PTEN-deficient tumor cells to genotoxic stress.
  • To evaluate PARG depletion as a potential therapeutic strategy for specific cancer types.

Main Methods:

  • PARG was depleted using siRNA in various cancer cell lines with different BRCA1 and PTEN statuses.
  • Cell survival was assessed via colony formation and viability assays.
  • Homologous recombination (HR) efficacy was evaluated by RAD51 foci and an in vivo HR assay.

Main Results:

  • BRCA1-deficient cell lines showed mild sensitivity to PARG depletion, while proficient cell lines did not.
  • Restoring BRCA1 in deficient cells did not alter sensitivity to PARG depletion.
  • Simultaneous depletion of PARG with BRCA1 or PTEN did not increase cytotoxicity compared to single depletions.

Conclusions:

  • PARG depletion induced slight sensitivity in some tumor cells, but this was not linked to BRCA1 or PTEN deficiency.
  • PARG depletion is unlikely to be an effective strategy for targeting tumors with BRCA1 or PTEN mutations.
Keywords:
BRCACancerHomologous recombinationPoly(ADP-ribose)Synthetic lethality

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.7K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

15.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K